(Q24244334)

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Liver haemodynamics and function in alcoholic cirrhosis. Relation to testosterone treatment and ethanol consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

No Effect of Oral Testosterone Treatment on Sexual Dysfunction in Alcoholic Cirrhotic Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Serum testosterone concentrations in men with alcoholic cirrhosis: Background for variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Testosterone treatment of men with alcoholic cirrhosis: A double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Short-Term Parenteral and Peroral Testosterone Administration in Men with Alcoholic Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Subgroup analysis and other (mis)uses of baseline data in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Practical aspects in data monitoring: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Anabolic/androgenic steroid abuse and thrombosis: is there a connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Hypothalamic–Pituitary–Gonadal Function in Relation to Liver Function in Men with Alcoholic Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Anabolic-androgenic steroid treatment of liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

AGA technical review on parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Alcoholic liver disease: new insights in pathogenesis lead to new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

A consumer's guide to subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Propylthiouracil for alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

S-adenosyl-L-methionine for alcoholic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Alcohol-induced hepatic injury in nonalcoholic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Do certain countries produce only positive results? A systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Anabolic-androgenic steroids for alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Augmented release of hepatic triglycerides with anabolic steroids in patients with fatty liver

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

PROTEIN METABOLISM, EXCRETION, AND DETOXICATION FUNCTIONS OF THE LIVER AFTER LONG-TERM TREATMENT OF LIVER CIRRHOSIS WITH AN ANABOLIC SUBSTANCE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Prednisolone and testosterone propionate in cirrhosis of the liver. A controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Controlled study of the therapeutic effect of B vitamins and an anabolic steroid in chronic hepatitis (author's transl)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

LONG-TERM TREATMENT OF CHRONIC LIVER DISEASES WITH PREDNISOLONE AND METHANDROSTENOLONE. PRELIMINARY REPORT

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

[Alcohol, liver cirrhosis and disorders in sex hormone metabolism]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Protein anabolism and fatty liver of the alcoholic

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Treatment of ascitic atrophic cirrhosis of the liver with high dosages of testosterone propionate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021

Anabolic Steroid Effect on Hepatic Protein Synthesis in Patients with Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045.PUB2

7 January 2021